BioCentury
ARTICLE | Company News

AngioGenex, BioCheck cancer diagnostic deal

April 22, 2004 7:00 AM UTC

AngioGenex (New York, N.Y.) granted BioCheck (Foster City, Calif.) exclusive rights to develop and market cancer diagnostic and prognostic products based on AngioGenex's Id-gene technology. The compan...